Catalyst Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CBIO and buy or sell other stocks, options, and ETFs commission-free!About CBIO
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).
CEOHan Ying, PhD
CEOHan Ying, PhD
Employees7
Employees7
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1997
Founded1997
Employees7
Employees7
CBIO Key Statistics
Market cap19.42M
Market cap19.42M
Price-Earnings ratio-0.99
Price-Earnings ratio-0.99
Dividend yield—
Dividend yield—
Average volume55.99K
Average volume55.99K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$30.40
52 Week high$30.40
52 Week low$3.00
52 Week low$3.00